Tsuyoshi Kitajima

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Bipolar Disorder

Replacement Therapy

Mesenchymal Stem Cells

Top Venues

Psychiatry and clinical neurosciences

Acta psychiatrica Scandinavica

Bipolar disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Masashi Ikeda, Tsuyoshi Kitajima
Circadian variability of objective sleep measures predicts the relapse of a mood episode in bipolar disorder: findings from the APPLE cohort. Psychiatry and clinical neurosciences (2023)
Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima
Circadian variability of objective sleep measures predicts the relapse of a mood episode in bipolar disorder: findings from the APPLE cohort. Psychiatry and clinical neurosciences (2023)
Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima
Circadian variability of objective sleep measures predicts the relapse of a mood episode in bipolar disorder: findings from the APPLE cohort. Psychiatry and clinical neurosciences (2023)
Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima
Circadian variability of objective sleep measures predicts the relapse of a mood episode in bipolar disorder: findings from the APPLE cohort. Psychiatry and clinical neurosciences (2023)
Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Masashi Ikeda, Tsuyoshi Kitajima
Effect of nighttime bedroom light exposure on mood episode relapses in bipolar disorder. Acta psychiatrica Scandinavica 146 (1) (2022)
Yuichi Esaki, Kenji Obayashi, Keigo Saeki, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima
Preventive effect of morning light exposure on relapse into depressive episode in bipolar disorder. Acta psychiatrica Scandinavica 143 (4) (2021)
Yuichi Esaki, Ipei Takeuchi, Soji Tsuboi, Kiyoshi Fujita, Nakao Iwata, Tsuyoshi Kitajima
A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar disorders 22 (7) (2020)